This chart shows the National Cancer Center Network Guidelines, 2014, for use of the PSA test and Digital Rectal Exam (DRE) for early detection of prostate cancer. Recommendations for men over age 70 are below the chart.
In mouse models immune cell manipulation plus chemotherapy achieves prostate cancer remission where chemotherapy alone fails
Blocking or removing immune-suppressing cells , researchers at the University of California, San Diego School of Medicine have found, allows a special type of chemotherapy — and the immune cells it activates — to destroy prostate tumors.
Advocating for advanced prostate cancer patients in Scotland, Alister Walker, Chairman and volunteer in Perth & Kinross Prostate Cancer Support Group, writes in today’s online issue of the Scottish newspaper The Herald:
“Last week we read the good news that Moderator-Designate of the General Assembly of the Church of Scotland, the Reverend Dr Angus Morrison, has overcome the disease (Church leader in cancer warning , The Herald, April 23). With prostate cancer so often being symptomless in its early stages he is right to urge other men to consider speaking to their GP about the disease. This is particularly important for men aged over 50, black men and men whose father or brother has had the disease – who are at a higher risk.
Implantable device could allow doctors to test cancer drugs in patients before prescribing
PSA Rising– April 24, 2015, More than 100 drugs have been approved in the USA to treat cancer, but predicting which ones will help an individual patient is an inexact science. Patients may undergo weeks of noxious side effects before scans reveal that for this patient a particular drug is not working–even though it works for the patient in the next chair. A new implantable device, about the size of a grain of rice, may change that. Continue reading A Step Toward Personalized Chemotherapy→
Dr Leszek Kotula, co-author of the WAVE1 study, explains in this video from 2013 how basic science research in his lab at Upstate Medical University in Syracuse, NY will benefit prostate cancer patients with better diagnostic and treatment options.
April 7, 2015. Researchers at Upstate Medical University, NY and Harvard University have linked the loss of key gene, WAVE1, to a lethal form of prostate cancer. They found that in patients who were treated for prostate cancer, alterations in the WAVE1 gene were associated with a shorter remission.